Who Owns Gain Therapeutics, Inc. (GANX)?Hedge Fund & Institutional Holders
Institutional Holders
50
as of Q4 2025
Total Institutional Value
$4.000325220002e+82T
% of Float Held
4.047295597856334e+241%
QoQ Change in Holders
+14 / -11
Price History
GANX — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| Potomac Capital Management, Inc. | New Position | +1.0M | +$3.3M |
| JONES FINANCIAL COMPANIES LLLP | New Position | +702K | +$2.0M |
| Cambridge Investment Research Advisors, Inc. | Increased | +250K | +$436K |
| BENEDICT FINANCIAL ADVISORS INC | New Position | +38K | +$122K |
| Oliver Luxxe Assets LLC | New Position | +20K | +$65K |
| Apollon Wealth Management, LLC | New Position | +20K | +$63K |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | New Position | +16K | +$39K |
| SPROTT INC. | New Position | +12K | +$38K |
| FNY Investment Advisers, LLC | New Position | +2K | +$6K |
| State of Wyoming | New Position | +1K | +$4K |
| OMERS ADMINISTRATION Corp | New Position | +37K | +$0 |
| BNP PARIBAS FINANCIAL MARKETS | New Position | +2K | +$0 |
| MILLENNIUM MANAGEMENT LLC | New Position | +14K | +$0 |
| GSA CAPITAL PARTNERS LLP | New Position | +20K | +$0 |
| LPL Financial LLC | New Position | +107K | +$0 |
GANX — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| CITADEL ADVISORS LLC | Closed Position | -374K | -$661.2M |
| MORGAN STANLEY | Decreased | -8K | -$275.5M |
| UBS Group AG | Decreased | -60K | -$248.7M |
| RENAISSANCE TECHNOLOGIES LLC | Decreased | -109K | -$223.2M |
| XTX Topco Ltd | Closed Position | -54K | -$95.9M |
| Kovitz Investment Group Partners, LLC | Closed Position | -48K | -$84.2M |
| Squarepoint Ops LLC | Closed Position | -39K | -$68.2M |
| TWO SIGMA SECURITIES, LLC | Closed Position | -27K | -$48.4M |
| JPMORGAN CHASE & CO | Closed Position | -26K | -$46.5M |
| HighTower Advisors, LLC | Closed Position | -12K | -$20.5M |
| Bison Wealth, LLC | Closed Position | -11K | -$19.8M |
| Creekmur Asset Management LLC | Closed Position | -4K | -$7.9M |
| Arax Advisory Partners | Closed Position | -3K | -$5.8M |
| Virtu Financial LLC | Closed Position | -54K | -$96K |
Top Institutional Holders(Q4 2025)
GANX Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 49 | $17.7M | +14 |
| Q3 2025 | 35 | $5.7B | +4 |
| Q2 2025 | 31 | $10.5B | -2 |
| Q1 2025 | 33 | $7.3B | +8 |
| Q4 2024 | 25 | $7.5B | +5 |
| Q3 2024 | 20 | $2.2T | -6 |
| Q2 2024 | 26 | $1.4T | +1 |
| Q1 2024 | 25 | $5.0T | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 50 institutional investors hold GANX (Gain Therapeutics, Inc.). The largest holder is MARSHALL WACE, LLP with $4.0M in shares. This quarter, 14 institutions opened new positions and 11 closed their positions.
Frequently Asked Questions
How many hedge funds own GANX?
As of Q4 2025, 50 institutional investors report holding GANX (Gain Therapeutics, Inc.) in their 13F filings.
Who is the largest institutional holder of GANX?
The largest institutional holder of GANX is MARSHALL WACE, LLP with $4.0M in shares.
Is institutional ownership of GANX increasing or decreasing?
This quarter, 14 institutions opened new positions in GANX and 11 closed their positions.